Isofol Medical Correlations
| ISOFOL Stock | SEK 2.99 0.11 3.82% |
The current 90-days correlation between Isofol Medical AB and Alligator Bioscience AB is -0.13 (i.e., Good diversification). The correlation of Isofol Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Isofol Medical Correlation With Market
Good diversification
The correlation between Isofol Medical AB and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Isofol Medical AB and DJI in the same portfolio, assuming nothing else is changed.
Isofol |
The ability to find closely correlated positions to Isofol Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Isofol Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Isofol Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Isofol Medical AB to buy it.
Moving together with Isofol Stock
Moving against Isofol Stock
| 0.44 | NANOFS | Nanoform Finland Plc | PairCorr |
| 0.44 | KINV-B | Kinnevik Investment | PairCorr |
| 0.4 | KINV-A | Kinnevik Investment | PairCorr |
| 0.38 | GENO | Genovis AB | PairCorr |
| 0.37 | BIOA-B | BioArctic AB | PairCorr |
| 0.37 | CAMX | Camurus AB | PairCorr |
| 0.32 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.32 | EGTX | Egetis Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Isofol Stock performing well and Isofol Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Isofol Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XSPRAY | 2.20 | (0.23) | 0.00 | 0.62 | 0.00 | 5.26 | 25.50 | |||
| ONCO | 2.26 | (0.10) | 0.00 | 0.17 | 0.00 | 3.83 | 34.67 | |||
| HNSA | 2.34 | (0.77) | 0.00 | (7.12) | 0.00 | 3.40 | 21.12 | |||
| ATORX | 3.27 | (1.43) | 0.00 | (0.49) | 0.00 | 4.29 | 31.42 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Isofol Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |